UBS Group’s Isleworth Healthcare Acquisition Corporation Warrant ISLEW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,397
Closed 11599
2022
Q1
$0 Hold
2,397
﹤0.01% 11450
2021
Q4
$1K Hold
2,397
﹤0.01% 10185
2021
Q3
$1K Sell
2,397
-1,513
-39% -$990 ﹤0.01% 9414
2021
Q2
$3K Buy
+3,910
New +$2.31K ﹤0.01% 8896

Other funds holding ISLEW

UBS Group's ISLEW Position: Q2 2022 in Review

UBS Group sold out of Isleworth Healthcare Acquisition Corporation Warrant (ISLEW) in Q2 2022, closing a stake of 2,397 shares.

UBS Group first reported a position in ISLEW in Q2 2021 and held it in 4 quarters. The position peaked at $3K in Q2 2021. 46 funds tracked by Wall St. Rank hold ISLEW as of Q2 2022.

  • UBS Group reported no remaining Isleworth Healthcare Acquisition Corporation Warrant position as of Q2 2022 after selling out during the quarter.
  • UBS Group sold 2,397 Isleworth Healthcare Acquisition Corporation Warrant shares in Q2 2022.
  • UBS Group first reported a position in Isleworth Healthcare Acquisition Corporation Warrant in Q2 2021 and held it in 4 quarters.
  • UBS Group's Isleworth Healthcare Acquisition Corporation Warrant position peaked at $3K in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Warrant as of Q2 2022.

Based on UBS Group's 13F filing for Q2 2022, filed 10 Aug 2022.